Helen Of Troy Ltd SEC Filings

Helen of Troy Limited appointed its Chief Executive Officer, G. Scott Uzzell, to the Company’s Board of Directors effective November 4, 2025. He will serve as a director until the next annual general meeting of shareholders or until a successor is elected or appointed.

The Board does not plan to assign Mr. Uzzell to any Board committee, and he will not receive compensation for his Board service. The Board intends to nominate him for election at the next annual meeting. The Company states there are no arrangements or understandings tied to his appointment, no family relationships with current directors or officers, and no related person transactions under Item 404(a) of Regulation S‑K.

Helen of Troy Limited reported that Chief Legal Officer and Secretary Tessa N. Judge has notified the company of her voluntary resignation, effective November 28, 2025. The company stated the decision was personal to pursue another professional opportunity and was not due to any disagreement with the company.

Ms. Judge will continue in her role through the effective date to support a smooth transition, and the company expressed appreciation for her contributions and leadership.

Helen of Troy Limited reported weaker first-half fiscal 2026 results driven by softer consumer demand, tariff pressures and significant non-cash impairments. Consolidated net sales for the six months ended August 31, 2025 were $803.4 million, down 9.8% from prior year, with Organic declines largely in Beauty & Wellness and insulated beverageware categories. Management recorded substantial pre-tax asset impairment charges of approximately $326.4 million (including goodwill, indefinite-lived and definite-lived intangibles) and operating losses that reflect those write-downs. The Olive & June acquisition contributed $60.3 million to year-to-date sales; purchase consideration included initial cash of $224.7 million plus contingent consideration up to $15.0 million. Net leverage and covenant flexibility are in focus: $625 million of debt was hedged with swaps and credit facility headroom was effectively limited to $212.7 million; management expects to seek a temporary covenant amendment. Cost actions, working-capital measures and Project Pegasus initiatives were initiated to preserve liquidity.

Helen of Troy Ltd (HELE) Chief Financial Officer Brian Grass reported a sale of 322 common shares on 10/06/2025 at a price of $26.44 per share. The filing states these shares were withheld to satisfy estimated tax withholding tied to the vesting of previously granted restricted stock awards that vested on 10/04/2025. After the withholding, Mr. Grass beneficially owned 135,610 shares directly. The original grant was disclosed in a Form 4 filed on 10/10/2023. The Form 4 is signed by an attorney-in-fact on behalf of Mr. Grass on 10/08/2025.

Krista Berry, a director of Helen Of Troy Ltd (HELE), acquired 992 restricted common shares on 09/02/2025 that vested immediately. The grant included a tax-offset right that entitles Ms. Berry to receive a cash amount to cover certain tax liabilities related to the vesting. The transaction price is reported as $0, and after the acquisition Ms. Berry beneficially owned 7,865 common shares. The Form 4 lists the filing as by one reporting person and includes Exhibit 24 (Power of Attorney) as an attachment.

Elena Otero, a director of Helen Of Troy Ltd (HELE), reported a transaction dated 09/02/2025 in which 992 restricted common shares vested immediately and were treated as an acquisition at a $0 price due to grant/vesting mechanics. Following this transaction she beneficially owns 5,083 common shares. The filing notes the vested restricted stock is accompanied by a tax-offset right that provides a cash amount to cover certain tax liabilities arising on vesting. The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Tabata L. Gomez Sades, a director of Helen Of Troy Ltd (HELE), reported a change in beneficial ownership on a Form 4. On 09/02/2025 she was granted 992 common shares as restricted stock that vested immediately; the grant includes a tax-offset right to receive cash to pay related tax liabilities. The reporting shows a reported price of $0 for the award and indicates 5,083 common shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 09/03/2025. The filing is a routine disclosure of an insider equity award that became immediately vested.

Timothy F. Meeker, a director of Helen Of Troy Ltd (HELE), was granted 992 restricted common shares that vested immediately on 09/02/2025. The grant is accompanied by a tax-offset right that entitles the reporting person to receive a cash amount to pay certain tax liabilities arising from the vesting. After the transaction, Meeker beneficially owns 10,758 common shares. The Form 4 was signed by an attorney-in-fact on 09/03/2025 and lists Exhibit 24 (Power of Attorney).